XML 43 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues [Abstract]        
Net revenues $ 117,251 $ 113,122 $ 359,855 $ 336,562
Operating costs:        
Salaries and related costs 66,748 64,524 203,684 191,410
Rent, supplies, contract labor and other 22,166 21,654 67,236 65,598
Provision for doubtful accounts 962 890 3,408 3,102
Closure costs 3 (22) 12 8
Total operating costs 89,879 87,046 274,340 260,118
Gross Profit 27,372 26,076 85,515 76,444
Corporate office costs 10,556 10,643 33,376 30,934
Operating income 16,816 15,433 52,139 45,510
Other income and expense        
Gain on sale of partnership interest 0 0 5,823 0
Interest and other income, net 7 16 27 70
Interest expense (557) (579) (1,522) (1,677)
Income before taxes 16,266 14,870 56,467 43,903
Provision for income taxes 3,197 2,991 11,223 8,734
Net income 13,069 11,879 45,244 35,169
Less: net income attributable to non-controlling interests:        
Non-controlling interests - permanent equity (1,643) (1,321) (4,982) (3,902)
Redeemable non-controlling interests - temporary equity (2,379) (2,456) (8,152) (6,802)
Less: net income attributable to non-controlling interests (4,022) (3,777) (13,134) (10,704)
Net income attributable to USPH shareholders $ 9,047 $ 8,102 $ 32,110 $ 24,465
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.66 $ 0.13 $ 1.90 $ 0.88
Shares used in computation - basic and diluted (in shares) 12,774 12,685 12,750 12,660
Dividends declared per common share (in dollars per share) $ 0.30 $ 0.23 $ 0.84 $ 0.69
Net Patient Revenues [Member]        
Revenues [Abstract]        
Net revenues $ 104,392 $ 103,354 $ 324,405 $ 309,895
Other Revenues [Member]        
Revenues [Abstract]        
Net revenues $ 12,859 $ 9,768 $ 35,450 $ 26,667